Research News

The Impact of BMI on IP Therapy

(May 25, 2016) A new study published in the International Journal of Gynecological Cancer earlier this month investigated the impact of body mass index (BMI) on completion, complications, and clinical outcomes of intraperitoneal (IP) chemotherapy in…

Read on

Webinar: Clinical Trials: What you need to know

Oliver Dorigo, MD, PhD, Director of the Stanford Gynecologic Oncology Clinical Care Program and Director of Stanford Obstetrics and Gynecology’s Division of Gynecologic Oncology provided an introduction to clinical trials for ovarian cancer…

Read on

Long Term Survival Study Recruiting Participants

The Consortium for Long-Term Survival — is bringing together research groups worldwide…

Read on

OCRFA Research Helps Explain Resistance to Chemotherapy

(May 4, 2016) Research funded in part by an OCRFA research grant to Dr…

Read on

Irregular Periods May Increase Ovarian Cancer Risk

Research published last month in the International Journal of Cancer showed an unexpected finding: young women with irregular menstrual periods may be at higher risk of developing—and dying from—ovarian cancer later in life…

Read on

Irregular Periods May Increase Ovarian Cancer Risk

(May 2, 2016) Research published last month in the International Journal of Cancer showed an unexpected finding: young women with irregular menstrual periods may be at higher risk of developing—and dying from—ovarian cancer later in life…

Read on

Stand Up To Cancer Supports “Innovation in Collaboration” in Cancer Research

Stand Up To Cancer Supports “Innovation in Collaboration” in Cancer Research with $1 Million for Five Teams through Phillip A…

Read on

Hormone Therapy Safe After Nonserous Ovarian Cancer

(April 25, 2016) New findings published online this month in Obstetrics and Gynecology suggest that hormone therapy (HT) can be used safely to manage menopausal symptoms in women who have undergone treatment for nonserous epithelial ovarian cancer…

Read on

Hormone Therapy Safe After Nonserous Ovarian Cancer

New findings published online this month in Obstetrics and Gynecology suggest that hormone therapy (HT) can be used safely to manage menopausal symptoms in women who have undergone treatment for nonserous epithelial ovarian cancer…

Read on

OCRFA Statement on Results of GOG 252

Many members of the ovarian cancer community have been concerned about the results of GOG 252 clinical trial, which were released last month at the Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer…

Read on

Research Update: Updated ICON6 Final Progression Free Survival analysis

The Lancet has recently published an update to the progression-free survival (PFS) data of theICON6 trial.  (The preliminary data was first presented at the European Society of Medical Oncology congress in 2013…

Read on

Updated ICON6 Final Progression Free Survival analysis

(March 31, 2016) The Lancet has recently published an update to the progression-free survival (PFS) data of the ICON6 trial.  (The preliminary data was first presented at the European Society of Medical Oncology congress in 2013…

Read on